human
adenovir
vector
demonstr
great
potenti
vaccin
vector
preclin
clinic
studi
demonstr
feasibl
vector
design
robust
antigen
express
protect
immun
use
system
howev
clinic
use
adenovir
vector
vaccin
purpos
anticip
limit
vector
immun
either
preexist
develop
rapidli
follow
first
inocul
adenovir
vector
vector
immun
inactiv
vector
particl
rapidli
remov
transduc
cell
therebi
limit
durat
transgen
express
due
strong
vector
immun
subsequ
use
vector
usual
less
effici
order
circumv
limit
nonhuman
adenovir
vector
propos
altern
vector
addit
elud
immun
vector
possess
attract
featur
vector
sever
replicationcompet
replicationdefect
nonhuman
adenovir
vector
develop
investig
potenti
vaccinedeliveri
vector
review
recent
advanc
design
character
variou
nonhuman
adenovir
vector
discuss
potenti
applic
human
anim
vaccin
advanc
recombin
dna
technolog
genom
immunolog
greatli
impact
process
vaccin
develop
genet
manipul
microb
adapt
vector
gene
deliveri
offer
uniqu
opportun
vaccin
design
effect
novel
safe
vaccin
sought
exist
emerg
reemerg
diseas
viral
bacteri
vector
becom
import
immunoprophylact
tool
arsen
modern
medicin
advantag
vector
vaccin
includ
effici
antigen
present
induct
humor
cellmedi
immun
among
variou
vaccin
vector
adenovir
ad
vector
extens
investig
sinc
first
use
ad
express
vector
earli
ad
vector
shown
great
promis
vaccin
vector
addit
ad
vector
extens
explor
applic
gene
therapi
ad
vector
also
becom
therapeut
tool
cancer
therapi
virtu
oncolyt
natur
sever
preclin
clinic
trial
demonstr
therapeut
potenti
ad
vector
treatment
varieti
cancer
ad
vector
also
explor
genet
immunotherapi
tumor
clinic
modal
conjunct
convent
chemoand
radiationtherapi
ad
vector
offer
sever
advantag
vaccin
vector
meet
import
criteria
ideal
vaccin
vector
term
efficaci
safeti
stabil
ad
infect
broad
rang
activ
divid
well
postmitot
quiescent
mammalian
cell
transgen
express
ad
vector
usual
robust
enhanc
drive
gene
express
strong
heterolog
promot
gener
variou
ad
vector
fairli
straightforward
vector
easili
grown
larg
scale
tissu
cultur
sinc
ad
vector
replicationdefect
seriou
threat
horizont
transmiss
vector
genom
integr
host
chromosom
mostli
remain
epichromosom
thu
make
use
safe
without
potenti
risk
insert
mutagenesi
ad
vector
induc
strong
immun
administ
via
parenter
subcutan
intraven
intramuscular
intraperiton
mucos
oral
intranas
rout
latter
often
desir
infect
occur
mucos
surfac
furthermor
ad
vector
appear
safe
use
human
human
ad
serotyp
use
live
oral
vaccin
militari
recruit
usa
sever
decad
without
known
advers
effect
although
mechan
immun
respons
foreign
antigen
express
ad
vector
fulli
understood
thought
involv
humor
cellular
arm
immun
system
follow
ad
vector
administr
foreign
gene
productspecif
antibodi
elicit
variou
experiment
anim
model
antibodi
primarili
isotyp
indic
predomin
thltype
help
addit
specif
cell
also
develop
ad
vector
also
induc
strong
innat
immun
respons
presum
potenti
subsequ
humor
cellular
immun
respons
furthermor
transduct
antigen
present
cell
ad
vector
facilit
antigen
present
prolong
durat
immun
respons
vaccin
studi
use
ad
vector
carri
serotyp
express
system
extens
use
deliveri
vehicl
major
ad
vectorbas
gene
therapi
trial
best
character
adenovirus
sever
recent
review
focus
prospect
vector
vaccin
number
preclin
clinic
trial
use
vector
vaccin
current
progress
notabl
among
vector
vaccin
ebola
viru
ev
elicit
protect
immun
challeng
ev
primat
ii
vector
vaccin
express
human
immunodefici
viru
hiv
env
gene
induc
protect
immun
hiv
rhesu
monkey
well
baboon
neutral
antibodi
monkey
iii
vector
express
protect
antigen
anthrax
show
effect
protect
anthrax
challeng
iv
vector
express
sever
acut
respiratori
syndrom
sar
corona
viru
protein
elicit
specif
immun
respons
rhesu
macaqu
ad
vector
also
use
passiv
immunotherapi
exemplifi
recent
studi
demonstr
product
singlechain
antibodi
direct
protect
antigen
bacillu
anthraci
despit
abovement
advantag
clinic
use
ad
vector
sever
hamper
wide
preval
preexist
immun
major
human
popul
efficaci
vector
expect
highli
variabl
depend
level
preexist
vector
immun
sinc
ad
vector
highli
immunogen
first
use
also
lead
develop
strong
humor
cellular
immun
block
subsequ
use
vector
potenti
problem
vaccin
strategi
requir
repeat
administr
suppress
effect
immun
attribut
strongli
neutral
antibodi
direct
viral
capsid
compon
cell
neutral
antibodi
lead
inactiv
free
ad
vector
thu
block
transduct
target
cell
prerequisit
antigen
express
fig
neutral
antibodi
drastic
reduc
uptak
ad
vector
cell
lead
poor
transgen
express
result
blunt
transgenespecif
immun
respons
inde
sever
studi
shown
drastic
reduct
genetransf
potenti
vector
preimmun
anim
model
specif
tlymphocyt
elimin
vector
transduc
cell
thu
shorten
durat
antigen
express
case
individu
preexpos
first
use
vector
lead
develop
strong
immun
make
subsequ
use
less
effect
fig
limit
live
viru
vector
vaccin
mani
vaccin
applic
warrant
one
doseboost
vaccin
order
elicit
protect
immun
preexist
immun
drastic
reduc
immunogen
vector
vaccin
anim
well
human
be
furthermor
sinc
level
neutral
antibodi
vari
wide
human
popul
immun
respons
follow
vaccin
vector
highli
variabl
larg
unpredict
therefor
preliminari
screen
target
individu
would
necessari
prior
use
vector
order
circumv
preexist
immun
sever
approach
investig
includ
prime
recombin
dna
prior
boost
vector
mucos
deliveri
vector
microencapsul
vector
inert
polym
engin
fiberor
hexonchimer
vector
use
ad
vector
base
rare
serotyp
use
vector
deriv
nonhuman
ad
type
focu
review
nonhuman
ad
vector
discuss
follow
section
adenovirus
isol
varieti
anim
speci
bird
base
genom
organ
serolog
properti
growth
cell
cultur
virus
group
four
distinct
genera
famili
adenovirida
mammalian
adenovirus
includ
known
serotyp
belong
genu
mastadenoviru
adenovirus
isol
bird
classifi
genu
aviadenoviru
genu
atadenoviru
consist
uniqu
virus
isol
ovin
bovin
deer
possum
well
bird
isol
virus
distinct
genu
mastadenoviru
lack
distinct
earli
region
el
transcript
unit
high
adenin
thymidin
rich
genom
recent
fourth
genu
siadenoviru
propos
includ
virus
isol
frog
invertebr
viru
caus
turkey
hemorrhag
enter
like
major
nonhumann
ad
chosen
vector
design
caus
signific
clinic
patholog
sign
natur
host
speci
sinc
ad
infect
widespread
major
adult
popul
host
speci
seroposit
preval
ad
serotyp
preced
use
nonhuman
ad
express
vector
primarili
came
low
pathogen
natur
host
similar
structur
genom
organ
case
mastadenoviru
speci
variou
nonhuman
ad
current
investig
gene
express
vector
includ
bovin
ad
serotyp
canin
ad
serotyp
chimpanze
ad
serotyp
exampl
simian
adenoviru
serotyp
ovin
ad
seortyp
porcin
ad
serotyp
fowl
ad
serotyp
tabl
greater
understand
biolog
nonhuman
ad
avail
suitabl
system
vector
rescu
propag
replicationcompet
well
replicationdefect
vector
construct
multipl
site
foreign
gene
insert
identifi
genom
variou
nonhuman
ad
fig
gener
twoplasmid
strategi
homolog
recombin
bacteria
gener
fulllength
recombin
ad
genom
follow
transfect
suitabl
elcompl
cell
line
fig
mainstay
nonhuman
ad
vector
construct
chimpanze
ad
vector
rescu
elcompl
cell
line
human
origin
follow
cotransfect
shuttl
plasmid
wildtyp
genom
dna
recombin
strategi
use
cosmid
also
use
addit
homolog
recombin
bacteria
fad
vector
develop
cotransfect
shuttl
plasmid
genom
dna
permiss
cell
line
fig
nonhuman
ad
vector
character
vivo
absenc
viru
neutral
antibodi
human
sera
suggest
virus
preval
human
popul
preexist
antibodi
sera
human
experiment
anim
crossneutr
nonhuman
ad
addit
vector
effici
transduc
sever
human
nonhuman
cell
indic
use
altern
vector
human
well
veterinari
use
present
review
recent
advanc
nonhuman
ad
vector
ten
ad
serotyp
isol
cattl
classifi
either
genu
mastadenoviru
atadenoviru
base
genom
organ
abil
grow
cell
cultur
bovin
ad
serotyp
mastadenoviru
isol
conjunctiva
healthi
cow
complet
nucleotid
sequenc
genom
map
reveal
high
level
similar
region
smaller
less
complex
essenti
viru
replic
tissu
cultur
recent
studi
compar
influenc
variou
promot
transgen
express
region
murin
cytomegaloviru
mcmv
immedi
earli
promot
effici
foreign
gene
express
orient
exogen
promot
phoshphoglycer
kinas
pgk
human
cytomegaloviru
hcmv
promot
develop
elcompl
cell
line
bovin
origin
import
requir
order
gener
replicationdefect
vector
sinc
elexpress
human
cell
line
support
replic
el
gene
product
shown
complement
function
demonstr
replic
eldelet
vector
infect
mdbk
cell
transcomplement
base
structur
function
homolog
el
gene
led
gener
complement
cell
line
transform
cell
bovin
origin
el
subsequ
replicationdefect
delet
andor
construct
homolog
recombin
e
coli
rescu
transfect
elcomplemet
bovin
retina
cell
vido
fbrt
fig
addit
bovin
cell
line
express
el
protein
also
develop
recent
genom
sequenc
involv
viru
packag
identifi
may
help
design
novel
vector
increas
carri
capac
preced
helperdepend
gutless
vector
abil
incorpor
heterolog
protein
cterminu
minor
capsid
protein
pix
protein
offer
uniqu
opportun
insert
specif
ligand
viral
capsid
improv
alter
transduct
vector
number
studi
demonstr
feasibl
gener
strong
immun
respons
foreign
gene
product
express
vector
mucos
immun
calv
replicationcompet
vector
carri
bovin
herpesviru
type
glycoprotein
gd
region
induc
neutral
antibodi
confer
protect
challeng
comparison
replicationdefect
replicationcompet
vector
express
gd
show
lower
immun
respons
elicit
replicationdefect
vector
import
note
vector
carri
foreign
gene
adenovir
major
late
promot
potenti
problem
lower
immun
respons
replicationdefect
vector
could
overcom
drive
transgen
express
strong
promot
hcmv
simian
viru
earli
promot
anoth
studi
investig
feasibl
gener
immun
respons
bovin
viral
diarrhea
viru
bvdv
glycoprotein
cotton
rat
use
vector
bvdv
iga
igg
respons
elicit
follow
intranas
immun
vector
sever
studi
examin
preexist
immun
role
subsequ
use
vector
cattl
popul
replicationcompet
vector
could
induc
protect
immun
respons
calv
preexist
antibodi
vector
could
also
circumv
preexist
immun
mous
model
recent
report
preval
human
popul
preexist
immun
crossneutr
studi
demonstr
potenti
vector
gene
transfer
human
even
presenc
neutral
antibodi
explor
possibl
import
vector
effici
transduc
human
cell
wildtyp
could
infect
grow
human
cell
line
replicationdefect
vector
effici
express
foreign
gene
varieti
human
well
nonhuman
cell
cultur
entri
variou
cell
type
appear
cara
well
integrinindepend
addit
tropism
could
alter
switch
viral
fiber
knob
fiber
knob
thu
indic
involv
receptor
distinct
primari
receptor
intern
two
serotyp
canin
ad
cad
isol
cadl
associ
mild
upper
respiratori
tract
infect
dog
effect
livemodifi
vaccin
avail
routin
vaccin
dog
cadl
excel
safeti
record
complet
genom
sequenc
cadl
known
cad
vector
express
capsid
protein
canin
parvoviru
gener
homolog
recombin
bacteria
well
character
util
vector
develop
genom
carri
eltranscript
region
similar
sinc
eldelet
vector
replic
human
elcompl
cell
line
elcomplemetnig
canin
kidney
cell
line
develop
express
el
protein
homolog
recombin
follow
cotransform
shuttl
plasmid
cad
genom
dna
e
coli
adapt
gener
recombin
infecti
clone
fig
condit
replic
vector
first
oncolyt
vector
base
nonhuman
ad
success
test
therapeut
applic
canin
osteosarcoma
avail
inform
regard
packag
sequenc
system
gener
helperdepend
vector
major
viral
genom
delet
develop
base
experi
commonli
use
live
cad
vaccin
observ
cad
vaccin
efficaci
vaccin
dog
parenter
rout
also
mucos
rout
replicationcompet
cad
vector
expect
use
provid
protect
immun
dog
wild
anim
varieti
pathogen
includ
rabi
replicationcompet
vector
express
canin
distemp
viru
cdv
hemagglutinin
fusion
protein
region
control
truncat
hcmv
promot
result
signific
seroconvers
protect
immun
intranas
vaccin
vector
induc
signific
level
cdvspecif
immun
seroneg
puppi
poor
immun
respons
elicit
puppi
preexpos
inabl
vector
vaccin
elicit
cdvspecif
serolog
respons
follow
intranas
inocul
attribut
mucos
immun
preexpos
anim
like
ad
cad
also
preval
natur
host
importantli
howev
neutral
antibodi
preval
human
vector
effici
transduc
varieti
human
cell
grow
cell
although
found
interact
car
tropism
distinct
indic
preferenti
transduct
nervou
tissu
novel
tropism
chimer
vector
carri
fiber
featur
help
design
altern
vector
target
gene
deliveri
nine
serotyp
chimpanze
ad
current
known
classifi
simian
ad
sad
mastadenoviru
genu
complet
nucleotid
sequenc
also
refer
pan
well
avail
group
subgroup
e
base
sequenc
homolog
genom
organ
virus
caus
appar
clinic
symptom
chimpanze
unlik
nonhuman
ad
initi
develop
vaccin
vector
natur
host
interest
toward
develop
gene
deliveri
vector
base
sad
gain
impetu
primarili
abil
circumv
preexist
immun
vector
close
homolog
transcomplement
el
function
sad
virus
el
anticip
first
eldelet
replicationdefect
recombin
carri
enhanc
green
fluoresc
protein
egfp
report
gene
rescu
homolog
recombin
human
elcompl
cell
line
fig
rescu
recombin
sad
vector
cell
line
complement
el
associ
potenti
risk
gener
replicationcompet
ad
vector
continu
effort
toward
develop
efficaci
vaccin
hiv
interest
grew
vector
vaccin
shown
great
promis
anim
model
preexist
immun
human
popul
may
dampen
initi
preclin
promis
vaccin
enter
clinic
trial
vaccin
therefor
investig
efficaci
safeti
potenti
altern
vector
vaccin
eldelet
vector
express
truncatedform
gag
antigen
induc
gagspecif
cell
respons
follow
oral
administr
mous
model
cell
respons
could
augment
systemicboost
immun
immun
use
vector
express
gag
antigen
induc
strong
antigenspecif
cellular
well
humor
respons
mice
well
monkey
recent
molecular
clone
three
sad
serotyp
also
refer
respect
develop
delet
el
sequenc
similar
elfunct
sad
serotyp
also
complement
el
replicationdefect
vector
could
propag
human
cell
variou
chimpanze
ad
includ
natur
preval
human
popul
panel
human
chimpanze
rhesu
monkey
serum
sampl
sampl
chimpanze
neutral
antibodi
human
rhesu
monkey
sampl
antibodi
preexist
immun
sever
common
serotyp
includ
reduc
antibodi
respons
transgen
express
vector
mous
model
preexposur
mice
replicationdefect
replicationcompet
blunt
antibodi
respons
follow
inocul
vector
affect
immun
vector
similar
observ
made
sad
serotyp
interestingli
antibodi
crossneutr
neutral
well
effici
transduc
human
hela
cell
sinc
variou
sad
serotyp
crossneutr
use
readministr
immunogen
chimpanze
ad
vector
effici
transduc
variou
human
cell
cultur
transduct
profil
vector
compar
shown
intern
via
car
receptor
ongo
research
provid
insight
safeti
efficaci
human
vaccin
seven
distinct
serotyp
ad
isol
sheep
refer
ovin
ad
serotyp
serotyp
assign
genu
mastadenoviru
serotyp
isol
nonpathogen
ad
sheep
uniqu
genom
organ
distinct
genu
mastadenoviru
aviadenoviru
complet
nucleotid
sequenc
avail
genom
character
high
content
lack
clearli
distinguish
el
region
owe
differ
along
ad
isol
deer
possum
duck
snake
etc
classifi
new
genu
atadenoviru
recombin
vector
construct
rescu
homolog
recombin
e
coli
follow
transfect
permiss
ovin
fetal
lung
cell
line
fig
anoth
effici
cosmidbas
strategi
vector
gener
follow
vector
rescu
ovin
fetal
skin
fibroblast
cell
line
also
develop
three
dispens
nonessenti
region
viral
genom
foreign
gene
insert
delin
refer
site
ii
iii
fig
site
locat
pviii
fiber
gene
site
ii
locat
toward
right
end
viral
genom
site
iii
locat
region
right
end
transcript
unit
recombin
vector
carri
transgen
insert
site
iii
stabl
make
prefer
region
foreign
gene
insert
biolog
potenti
gene
deliveri
applic
recent
review
number
recombin
vector
express
foreign
gene
encod
immunogen
protein
develop
recombin
express
hepat
c
viru
protein
elicit
strong
sustain
antigen
specif
tcell
respons
mice
high
level
transgen
express
follow
vector
administr
intraven
rout
vector
biodistribut
similar
spleen
heart
kidney
liver
lung
infect
lower
degre
similarli
high
serum
level
transgen
product
produc
follow
intramuscular
administr
vector
express
human
alpha
gene
mice
vector
express
taenia
ovi
antigen
w
antigen
insert
site
control
viral
major
late
promot
elicit
effect
immun
parasit
challeng
use
combin
dna
vaccin
primeboost
approach
recombin
vector
also
use
gene
therapi
recombin
vector
express
human
haat
gene
control
rou
sarcoma
viru
promot
use
investig
gene
transfer
potenti
vivo
distribut
vector
immunocompet
well
immunodefici
mous
model
level
durat
haat
gene
express
similar
achiev
counterpart
howev
tissuetrop
vector
differ
liver
domin
target
transgen
express
stabl
immunodefici
mice
impli
role
vector
immun
clearanc
transduc
cell
importantli
effici
gene
transfer
vector
mice
immun
vector
vice
versa
thu
underscor
potenti
vector
circumvent
immun
studi
investig
use
vector
genedirect
enzymeprodrug
therapi
approach
system
administr
singl
dose
recombin
vector
carri
e
coli
purin
nucleosid
phosphorylas
pnp
gene
follow
prodrug
fludarabin
phosphat
result
signific
suppress
prostat
cancer
progress
immunocompet
mous
model
serolog
survey
human
serum
sampl
indic
neutral
antibodi
preval
human
furthermor
neutral
antibodi
cross
neutral
antibodi
present
experiment
anim
imped
gene
transfer
vector
prevent
gene
transfer
vector
indic
potenti
vector
evad
immun
vector
effici
transduc
varieti
human
cell
cultur
importantli
infect
sever
nonovin
cell
test
abort
progeni
viru
could
detect
despit
replic
viral
dna
observ
signific
impact
respect
suitabl
safeti
vector
system
futur
use
human
although
receptor
involv
intern
known
appear
use
receptor
distinct
support
distinct
vivo
tropism
differenti
transduct
profil
well
alter
tropism
chimer
vector
carri
fiber
knob
domain
five
serotyp
porcin
ad
current
known
infect
pig
preval
serotyp
isol
healthi
piglet
associ
clinic
diseas
pig
known
natur
infect
speci
porcin
mastadenoviru
share
structur
genom
organ
genom
consist
distinct
transcript
region
replicationcompet
well
replicationdefect
vector
develop
gene
deliveri
vehicl
region
dispens
viru
growth
use
insert
foreign
gene
potenti
util
vaccin
purpos
demonstr
vector
construct
attempt
oral
vaccin
pig
stimul
system
mucos
viru
neutral
antibodi
first
use
recombin
pig
carri
vector
delet
carri
classic
swine
fever
viru
csfv
gene
cassett
right
hand
end
viral
genom
vector
induc
high
level
antibodi
follow
singl
subcutan
inocul
outbr
pig
lead
complet
protect
csfv
challeng
subsequ
primeboost
vaccin
strategi
involv
vaccin
wean
neonat
pig
first
dna
plasmid
carri
csfv
recombin
express
csfv
confer
complet
protect
experiment
csfv
challeng
wean
pig
vector
carri
pseudorabi
aujeszki
diseas
viru
prv
gd
gene
region
yield
high
level
prvspecif
antibodi
vaccin
pig
anim
receiv
two
dose
vector
show
improv
antibodi
titer
increas
protect
comparison
given
singl
dose
although
replicationcompet
pad
vector
may
use
vaccin
purpos
swine
use
heterolog
speci
includ
human
may
favor
due
safeti
concern
therefor
import
requir
potenti
applic
vector
speci
swine
render
replicationdefect
region
homolog
region
like
also
complement
function
reciproc
complement
function
number
cell
line
made
transform
porcin
retin
cell
transcomplement
facilit
gener
vector
porcin
cell
line
express
fig
mention
earlier
ad
wide
preval
natur
host
preval
serotyp
pig
survey
determin
extent
preexist
immun
australia
pig
test
signific
titer
viru
neutral
antibodi
consequ
concern
express
regard
suitabl
vector
use
swine
herd
howev
studi
pig
preexpos
wildtyp
prior
vaccin
recombin
vector
express
csfv
reveal
efficaci
vector
vaccin
inhibit
presenc
specif
neutral
antibodi
thu
vector
still
hold
great
potenti
use
swine
importantli
recent
report
preval
human
popul
indic
lack
neutral
antibodi
human
serum
sampl
neutral
antibodi
human
serum
cross
neutral
demonstr
effici
overcom
immun
mous
model
effici
transduc
cell
human
murin
porcin
bovin
origin
indic
use
gene
deliveri
vector
highli
speciesspecif
infect
replic
cell
canin
ovin
bovin
human
origin
unlik
transduct
appear
carand
integrinindepend
indic
distinct
tropism
potenti
applic
design
novel
target
vector
also
investig
potenti
gene
express
vector
origin
isol
japan
caus
seriou
diseas
pig
complet
genom
sequenc
avail
sinc
major
region
essenti
viru
replic
vector
carri
kb
gene
fragment
swine
transmiss
gastroenter
viru
tgev
region
construct
vector
induc
tgevspecif
system
well
mucos
immun
respons
follow
oral
administr
pig
sever
ad
isol
bird
includ
genu
aviadenoviru
three
serolog
group
ii
iii
avian
ad
egg
drop
syndrom
viru
includ
new
genu
atadenoviru
base
distinct
structur
genom
featur
group
aviadenoviru
includ
fowl
ad
fad
mostli
nonpathogen
caus
mild
infect
chicken
embryo
lethal
orphan
celo
isol
chicken
associ
diseas
inocul
specif
pathogenfre
spf
chicken
via
variou
rout
induc
antibodi
week
post
inocul
caus
advers
clinic
patholog
effect
distinct
mammalian
ad
possess
larger
genom
bp
two
fiber
rather
singl
fiber
vertex
viral
capsid
complet
nucleotid
sequenc
known
contain
recogniz
region
correspond
function
complement
howev
transform
mammalian
cell
induc
tumor
hamster
transform
gene
partial
character
uniqu
open
read
frame
encod
antiapoptot
protein
gallu
anti
mort
protein
protein
homologu
interact
retinoblastoma
protein
lead
pathway
transcript
activ
delet
gene
render
viru
replicationdefect
defect
could
partial
recov
induc
heat
shock
produc
cell
line
initi
vector
construct
use
classic
approach
homolog
recombin
bacteria
gener
recombin
ad
genom
follow
transfect
permiss
leghorn
male
hepatoma
lmh
cell
rescu
replicationcompet
vector
fig
cosmidbas
strategi
also
adopt
gener
recombin
delet
kb
could
introduc
map
unit
genom
allow
foreign
gene
insert
kb
fig
immun
chicken
recombin
vector
express
infecti
bursal
diseas
viru
ibdv
protein
provid
complet
protect
virul
ibdv
challeng
immun
induc
vector
similar
induc
fowlpox
viru
vector
marek
diseas
viru
vector
turkey
herpesviru
vector
thu
establish
util
vaccin
vector
recent
vector
also
examin
cancer
therapi
mous
model
subcutan
melanoma
effici
transduc
primari
human
dermal
fibroblast
cell
effici
compar
vector
sinc
infect
replic
varieti
human
porcin
equin
simian
cell
line
vector
may
also
potenti
applic
vaccin
nonavian
speci
addit
also
explor
develop
express
vector
oral
vaccin
broiler
chicken
recombin
express
gene
infecti
bronchiti
viru
ibv
insert
kb
bp
delet
site
genom
elicit
ibv
antibodi
respons
singl
vaccin
found
impart
protect
immun
challeng
homolog
ibv
anoth
recombin
vector
express
chicken
interferon
gamma
use
vivo
deliveri
cytokin
test
abil
boost
immun
coccidi
parasit
chicken
delet
long
tandem
repeat
region
toward
right
end
viral
genom
lethal
insert
report
gene
well
toler
manipul
significantli
alter
distribut
replic
immun
respons
compar
parent
viru
recombin
vector
express
ibdv
construct
insert
express
cassett
right
end
genom
map
unit
upstream
invert
termin
repeat
intraven
inocul
recombin
vector
bird
result
protect
immun
ibdv
howev
vector
instil
conjunctiv
sac
mucos
rout
fail
elicit
signific
immun
ibdv
highlight
import
rout
administr
success
vaccin
use
fad
vector
clinic
use
vector
hamper
vector
immun
preval
major
human
popul
also
develop
rapidli
first
use
vector
nonhuman
ad
preval
human
crossneutr
neutral
antibodi
signific
progress
made
understand
biolog
vector
vector
effici
transduc
human
cell
cultur
circumv
preexist
immun
ever
increas
number
preclin
clinic
studi
demonstr
util
vector
therapeut
prophylact
gene
deliveri
provid
momentum
research
effort
area
develop
nonhuman
ad
vector
addit
nonhuman
ad
vector
also
present
platform
design
improv
vaccin
veterinari
use
nonhuman
ad
vector
present
review
shown
initi
promis
gene
transfer
human
cell
evas
immun
investig
need
use
human
could
becom
realiti
import
concern
nonhuman
ad
vector
would
safeti
human
despit
fact
nonhuman
ad
vector
replicationdefect
human
cell
delet
essenti
gene
lead
blunt
viral
replic
thorough
examin
viral
gene
express
viral
genom
persist
varieti
human
cell
nonhuman
primat
model
necessari
ascertain
safeti
vector
similarli
inform
regard
packag
sequenc
receptor
util
determin
tissu
tropism
vivo
persist
state
vector
genom
determin
rel
use
vector
although
preliminari
studi
shown
feasibl
sequenti
administr
variou
nonhuman
ad
vector
aspect
need
investig
suitabl
anim
model
import
investig
whether
humor
immun
respons
nonhuman
ad
vector
crossneutr
nonhuman
ad
vector
inform
use
devis
strategi
booster
vaccin
feasibl
construct
minim
genom
ad
vector
gutless
gut
delet
major
viral
gene
order
increas
durat
express
target
gene
packag
capac
nonhuman
ad
vector
need
explor
vector
use
develop
vector
carri
multipl
gene
encod
antigen
andor
immunomodulatori
protein
care
assess
optim
dose
vector
associ
vector
toxic
would
also
requir
purpos
develop
appropri
laboratori
anim
model
logic
nextstep
